Seeking to fight the recent Covid subvariants of Omicron, US pharma giant Pfizer on Monday sought emergency authorisation for its COVID-19 booster dose for school-age children aged 5 to 11.

Pfizer-BioNTech file for emergency use approval for its Covid booster for children aged 5-11

This week, it's anticipated that the Food and Drug Administration would approve new COVID-19 booster shots without the results from a trial demonstrating whether the shots were secure and effective in humans, which is a crucial component of its typical decision-making process.

New COVID-19 boosters set to launch before human testing is complete

The Biden administration is planning to give Americans age 50 or older the option of a second booster of the Pfizer or Moderna coronavirus vaccine without recommending outright that they get one, according to several people familiar with the plan.

Biden administration plans to offer second booster shots to those 50 and older

For the 1st time in 14 days, daily cases decreased due to lower testing over the weekend. Amid the battle against coronavirus, India began its booster program for frontline workers and for those above the age of 60.

3rd Covid dose for healthcare workers, senior citizens